LATEST ALERTS
HHC is the most popular intoxicating hemp-derived cannabinoid (IHDC) in Europe, while delta-8 THC remains top in the US, according to CannIntelligence analysts
National Assembly member Christophe Bex hopes to spearhead efforts to legalise cannabis in France and could draft legislation aimed at doing just that
The Regional Administrative Court (TAR) of Lazio has anulled an Italian government decree on officinal plants which put the use of hemp flowers and leaves under narcotics law
Cold-pressed hemp oils appear to provide a way for CBD producers to circumvent UK rules on novel foods – but while some are all in favour, others see dangers and shortcomings
An expert working group preparing an outline proposal for the regulation of the recreational cannabis market in the Czech Republic has released a provisional set of recommendations
The European Commission has issued a proposal for a revision of EU legislation on packaging and packaging waste, which could have profound long-term consequences for the CBD and potential cannabis industries
Recent criticism from the Swiss canton of Bern on a pilot study to legalise and sell recreational cannabis in pharmacies will have no impact on plans to carry on with the project
Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US
US cannabis firm Curaleaf has denied having any secret financial ties to the Russian billionaire Roman Abramovich, who has been sanctioned in the UK and EU since the outbreak of the war in Ukraine
British CBD and hemp brand Voyager has facilitated easier access to the EU market by acquiring a CBD extraction and manufacturing facility in Poland for £1.5m (€1.69m)
The European Food Safety Authority denies it is waiting research results on the safety of CBD by the US Food and Drug Administration before it lets validated candidates complete the novel food application process
US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
Belgium has set new rules for nicotine-free e-liquids, effectively banning all e-liquids containing CBD – and thereby setting up a possible conflict with EU law
CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies
Cannabis consumption is a growing problem in Bavaria and its planned legalisation in Germany would further burden the country’s health system, Bavarian health minister Klaus Holetschek says
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
The German Ministry of Health’s budget has been slashed by €1m in a bid to put pressure on health minister Karl Lauterbach to present a draft law for the legalisation of cannabis
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
A decision by Germany’s Federal Social Court limiting the prescribing and insurance payment for medical cannabis has been described by a leading lawyer on cannabis issues as “disturbing”
Ukraine’s parliament will continue to consider a bill to legalise medical cannabis beyond the current legislative session because of the expected need stemming from the Russian invasion of the country
Budget supermarket chain Aldi’s CBD products are out of stock in the UK and there’s no indication of when, or indeed whether, they will be restocked
A CBD company in Belgium has proved in court that local authorities in the country do not have the right to gold-plate regulations to prohibit the sale of hemp-based cannabinoid products
A test case has demonstrated that the ECHR doesn’t consider access to cannabis to be a universal human right, and balancing a cannabis user’s human rights with public interest is best left to sovereign states
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
CBD isolate producers in the UK are waiting to see whether and how toxicological data released by the European Industrial Hemp Association (EIHA) will affect their novel food applications to the Food Standards Agency (FSA)
Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
